HALOVATE Halobetasol Propionate 0.05% Cream 30g
RXDRUG-DR-XY41151
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
Relief of inflammatory & pruritic manifestations of corticosteroid responsive dermatoses.
Dosage/Direction for Use
Wash affected area w/ soap & water. Apply a thin film into the affected area bid.
Contraindications
Hypersensitivity. Skin TB, chicken pox, herpes simplex, measles, vaccinia, perioral dermatitis, acne rosacea/vulgaris, syphilitic skin lesions & untreated bacterial, fungal, or viral skin lesions. Pregnancy. Childn <12 yr.
Special Precautions
Not for ophth, oral or intravag use. Avoid using large amounts & over large areas of the body & contact w/ face, axillae, perianal region, genitalia, eyes & mucous membranes. Discontinue treatment if irritation develops. Patients w/ history of allergic-type responses to other topical or oral corticosteroids; history of preexisting skin atrophy & peripheral vascular disease; diabetes; history of immunosuppression & immunocompromised patients. Concomitant use w/ systemic antifungal or steroid treatment. Lactation.
Adverse Reactions
Stinging, burning, itching.
MedsGo Class
Topical Corticosteroids
Features
Brand
Halovate
Full Details
Dosage Strength
0.05% w/w
Drug Ingredients
- Halobetasol
Drug Packaging
Cream 30g
Generic Name
Halobetasol Propionate
Dosage Form
Cream
Registration Number
DR-XY41151
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply